1. Home
  2. OTEX vs LGND Comparison

OTEX vs LGND Comparison

Compare OTEX & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Open Text Corporation

OTEX

Open Text Corporation

N/A

Current Price

$24.88

Market Cap

6.2B

Sector

Technology

ML Signal

N/A

Logo Ligand Pharmaceuticals Incorporated

LGND

Ligand Pharmaceuticals Incorporated

N/A

Current Price

$314.28

Market Cap

6.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
OTEX
LGND
Founded
1991
1987
Country
Canada
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.2B
6.0B
IPO Year
1998
1997

Fundamental Metrics

Financial Performance
Metric
OTEX
LGND
Price
$24.88
$314.28
Analyst Decision
Hold
Strong Buy
Analyst Count
12
11
Target Price
$28.14
★ $361.27
AVG Volume (30 Days)
★ 1.4M
183.8K
Earning Date
11-05-2026
10-29-2026
Dividend Yield
★ 4.49%
N/A
EPS Growth
56.36
★ 2886.36
EPS
★ 0.64
0.31
Revenue
★ $2,815,241,000.00
$141,102,000.00
Revenue This Year
N/A
$8.82
Revenue Next Year
$1.67
$31.67
P/E Ratio
★ $38.98
$1,028.35
Revenue Growth
22.88
★ 29.48
52 Week Low
$19.78
$175.89
52 Week High
$34.17
$326.63

Technical Indicators

Market Signals
Indicator
OTEX
LGND
Relative Strength Index (RSI) 45.09 54.39
Support Level $21.70 $277.97
Resistance Level $25.57 $319.83
Average True Range (ATR) 0.70 11.02
MACD -0.34 -0.13
Stochastic Oscillator 20.71 60.62

Price Performance

Historical Comparison
OTEX
LGND

About OTEX Open Text Corporation

Open Text Corp provides data management for enterprise AI, offering a secure data foundation and trusted context for credible AI outcomes across private, public, and sovereign cloud, managed cloud services, API, and on-premises environments. The Company also provides cybersecurity solutions to protect sensitive data, applications and systems across complex hybrid environments, including identity and access management, threat detection and response, data protection and application security. It serves private, public, and regulated sectors, including retail, financial services, government, manufacturing, healthcare, energy, and logistics, with clients. Geographically, it derives maximum revenue from the Americas.

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

Share on Social Networks: